Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan:234:108911.
doi: 10.1016/j.clim.2021.108911. Epub 2021 Dec 18.

Association of KIR gene polymorphisms with COVID-19 disease

Affiliations

Association of KIR gene polymorphisms with COVID-19 disease

Ali Hajeer et al. Clin Immunol. 2022 Jan.

Abstract

Background: Natural killer (NK) cells play an essential role against viruses. NK cells express killer cell immunoglobulin-like receptors (KIRs) which regulate their activity and function. The polymorphisms in KIR haplotypes confer differential viral susceptibility and disease severity caused by infections. We investigated the association between KIR genes and COVID-19 disease severity.

Methods: 424 COVID-19 positive patients were divided according to their disease severity into mild, moderate and severe. KIR genes were genotyped using next generation sequencing (NGS). Association between KIR genes and COVID-19 disease severity was conducted and significant correlations were reported.

Results: In the COVID-19 patients, KIR Bx genotype was more common than AA genotype. The Bx genotype was found more frequently in patients with mild disease, while in severe disease the AA genotype was more common than the Bx genotype. The KIR2DS4 gene carried the highest risk for severe COVID-19 infection (OR 8.48, pc= 0.0084) followed by KIR3DL1 (OR 7.61, pc= 0.0192).

Conclusions: Our findings suggest that KIR2DS4 and KIR3DL1 genes carry risk for severe COVID-19 disease.

Keywords: COVID-19; KIR; Natural killer; Risk; SARS CoV-2; Saudi Arabia; Virus.

PubMed Disclaimer

References

    1. Vetter P., Vu D.L., L’Huillier A.G., Schibler M., Kaiser L., Jacquerioz F. Vol. 369. 2020. Clinical Features of Covid-19. - PubMed
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. - PMC - PubMed
    1. Maucourant C., Filipovic I., Ponzetta A., Aleman S., Cornillet M., Hertwig L., Strunz B., Lentini A., Reinius B., Brownlie D. Natural killer cell immunotypes related to COVID-19 disease severity. Sci. Immunol. 2020;5(50) - PMC - PubMed
    1. De Maria A., Bozzano F., Cantoni C., Moretta L. Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-γ on activation. Proc. Natl. Acad. Sci. 2011;108(2):728–732. - PMC - PubMed
    1. Mossman K.L., Ashkar A.A. Herpesviruses and the innate immune response. Viral Immunol. 2005;18(2):267–281. - PubMed